These people more likely to have breakthrough COVID infections
Scientists from Case Western Reserve University found that breakthrough COVID-19 cases resulting in infections, hospitalizations and deaths are significantly more likely in cancer and...
Omicron BA.2 does not cause more severe illness than BA.1
Scientists from the University of Wisconsin–Madison found that the BA.2 subvariant of omicron is similar to BA.1 in both the severity of illness it...
Scientists finds who is most at risk to get long COVID
Scientists from Hiroshima University found that having a mild case of COVID-19, smoking status, comorbidities, or your gender aren't significant predictors to tell if...
Despite the uncertainty, there is hope for long COVID patients
It’s estimated one in 10 people infected with SARS-CoV-2 will have lingering symptoms, but most people will improve over time.
As the world came to...
This study shows the cause of severe inflammation in COVID-19
Clinical evidence showed that the leading cause of death in COVID-19 patients is the dangerous condition known as a cytokine storm.
Scientists from the University...
COVID-19 leads to high blood clot risk
Scientists from the University of Oxford found that around 1 in 100 people with COVID-19 developed dangerous blood clots, with rates higher in men,...
‘Natural immunity’ from COVID-19 omicron is weak and limited
Scientists from Gladstone Institutes and UC San Francisco found that in unvaccinated people, infection with the omicron variant of COVID-19 provides little long-term immunity...
This hormone treatment may reduce COVID-19 deaths
Scientists from the University of Southampton found that receiving hormone replacement therapy within six months of a recorded diagnosis of COVID-19 was linked to...
Scientists find a new treatment option for COVID-19
Scientists from RCSI University of Medicine and Health Sciences found an effective treatment for critically ill COVID-19 patients.
They found that using an anti-inflammatory protein,...
This drug could benefit people with severe COVID-19
Scientists from Amsterdam University Medical Centers found that patients with severe COVID-19 who were given imatinib had lower death risk at 90-day follow-up.
The research...